Elevance had a great earnings despite the reaction from Wall Street as it was down more than 5% (over $25) yesterday and does not look much better in the pre market this morning. That being said, they grew top line quarter over quarter 10.6% across the board to over 42 billion (up from 38 billion in 2022) with Carelon being the star with growth of 17.7%…
Keep reading with a 7-day free trial
Subscribe to The Healthcare Economy to keep reading this post and get 7 days of free access to the full post archives.